The inflammation-repair cycle in asthma: The pivotal role of the airway epithelium

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 5, 1998, Pages 97-103

  Holgate, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; CORTICOSTEROID; CYTOKINE; IMMUNOGLOBULIN E;

ANTIGEN PRESENTING CELL; ASTHMA; ATOPY; CELLULAR IMMUNITY; CONFERENCE PAPER; DRUG TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; T LYMPHOCYTE ACTIVATION;

EID: 0031765612     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.028s5097.x     Document Type: Conference Paper

References (62)

1. Van Leeuwen BH, Martinson ME, Webb GC, Young IG. Molecular organisation of the cytokine gene cluster, involving the human IL, IL-4, IL-6 and GM-CSF genes on human chromosome 5. Blood 1989; 73:1142-8.
2. Lee TH. Cytokine networks in the pathogenesis of bronchial asthma: implications for therapy. J Roy Coll Phys Lond 1998; 32:56-64.
3. + T cells, eosinophils and mast cells in bronchial biopsies obtained from atopic and non-atopic (intrinsic asthmatics). J Immunol 1997; 158:3539-44.
4. Maestrelli P, Di Stefano A, Occari P, Turato G, Milani G, Pivirotto F, Mapp CE, Fabbri LM, Saetta M. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. Am J Respir Crit Care Med 1995; 151:607-12.
5. Fick RB, Simon SJ, Su JQ, Zeiger R. Anti-IgE (rhu MAb) treatment of the symptoms of moderate-severe allergic asthma. J Allergy Clin Immunol 1998; in press: (abstract).
6. Fahy JV, Flemming HE, Wong HH, Lia JT, Su JQ, Riemann J, Pick RB Jr, Boushey HA. The effect of an anti-IgE monoclonal antibody on the early and late phase response to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:1828-34.
7. Melhop PD, Van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin JR, Oettgen HL. Allergen-induced bronchial hyperreactivity and eosinophilic inflamamtion occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci (Usa) 1997; 94:1344-9.
8. Durham SR, Gould HJ, Thienes CP, Jacobson MR, Masuyama K, Rak S, Löwhagen O, Schofman E, Cameron L, Hamid QA. Expression of ε germ-line transcripts and mRNA for the ε heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997; 27: 2899-096.
9. Bellini A, Vittori B, Marini M, Ackerman V, Mattoli S. Intraepithelial dendritic cells and selective activation of Th-2 like lymphocytes in patients with atopic asthma. Chest 1993; 103:997-1005.
10. Roberts K, Jaffar ZH, Semper AE, Holgate ST. Asthma: Clinical aspects and mucosal immunity. in: Mucosal Immunol (Eds Ogra PL, Mestecky J, Lamm ME, Strober W, Mcghee JR, Bienenstock J), Academic Press, New York 1998; in press:
11. Semper AE, Hartley JA. Dendritic cells in the lung: what is their relevance to asthma? Clin Exp Allergy 1996; 26:485-90.
12. Semper AE, Hartley JA, de Tunon Lara JM, Bradding P, Redington AE, Church MK, Holgate ST. Expression of the high affinity receptor for immunoglobulin E (IgE) by dendritic cells in normals and asthmatics. In: (Banchereau J, Schmitt D (eds)) Dendritic Cells in Fundamental and Clinical Immunology, Vol. 2: New York, Plenum Publishing Co 1996 pp. 135-8.
13. Maurer D, Fiebiger E, Reininger B, Fischer G, Wichlas S, Jouvin MH, Schmitt Egenolf M, Kraft D, Kinet J-P, Stingl G. Peripheral blood dendritic cells express FcεR1 as a complex composed of FcεR1α and FcεR1γ chains can use this receptor for IgE-mediated allergen presentation. J Immunol 1996; 157:607-16.
14. Jaffar Z, Roberts K, Pandit A, Holgate ST. B7 costimulation is required for iL-4 and IL-13 expression by t cells resident in bronchial biopsy tissue of asthmatics after allergen stimulation. Immunology 1997; 92:45 (abstract).
15. Harris N, Peach R, Naemura J, Linsley PS, Le Gros G, Rouchese F. CD80 costimulation is essential for the induction of airway eosinophilia. J Exp Med 1997; 185:177-82.
16. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N, Schuler G. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur J Immunol 1996; 26:659-68.
17. 2 promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997; 159:28-35.
18. Holtzman MJ, Castro M, Look DCL, O'Sullivan M, Walter MJ. Regulation of epithelial-leukocyte interaction and epithelial response genes. In: (Holgate ST, Busse W. (eds) Asthma and Rhinitis. 2nd Edn, Blackwell Sci, Oxford 1998; in press.
19. Werfel T, Morita A, Grewe M, Peng H, Wahn U, Krutmann J, Kapp A. Allergen specificity of skin-infiltrating T cells is not restricted to a Th2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 1996; 107:871-6.
20. Djukanovi R, Lai CWK, Wilson JW, Britten KM, Wilson SJ, Roche WR, Howarth PH, Holgate ST. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic non-asthmatics and healthy controls. Eur Respir J 1992; 5:538-44.
21. Lee S-C, Jaffar Z, Holgate ST, Roberts K. Lung inflammatory responses in T cell receptor transgenic mice. Immunology 1997; 92:85 (abstract).
22. Pender SLF, Tickle SP, Docherty AJP, Howie D, Wather NC, MacDonald TT. A major role for matrix metalloproteases in T cell injury in the gut. J Immunol 1997; 158:1582-90.
23. Robinson C, Carver JE. Interaction between eosinophils and the airway epithelium. In: Holgate ST, Busse W (eds) Inflammatory Mecahnisms in Asthma. Lung Biology in Health and Disease (series ed C. Lenfant), Marcel Dekker, New York 1998; in press.
24. Walls AF, Shute JK, Warner J, Cairns JA, Howarth PH, Holgate ST. Mast cell and eosinophil proteases in the chronic allergic inflammatory response. In: Austen KF, Lichtenstein LM, Kay AB, Holgate ST, Marone G (eds) Asthma: Physiology, Immunopharmacology and Treatment no. 5 Academic Press, London 1998; in press.
25. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: Role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997; 17:519-28.
26. Barnes PJ, Karin M. Nuclear factor-kappa B. a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-71.
27. Asano K, Nakamura H, Lilly CM, Klagsbrun M, Drazen JM. Interferon γ induces prostaglandin GIH synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells. J Clin Invest 1997; 99:1057-63.
28. Shibata Y, Nakamura H, Kato S, Tomoike H. Cellular detachment and deformation induce IL-8 gene expression in human bronchial epithelial cells. J Immunol 1996; 156:772-7.
29. Ricciardolo FLM, Geppett P, Mistretta A, Nadel JA, Sopienza MA, Bellofiore S. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 1996; 348:374-7.
30. 2. Lancet 1994; 345:436-8.
31. Borland G, Ross JA, Guy K. Forms and functions of CD44. Immunology 1998; 93:139-48.
32. Lackie PM, Baker JE, Günthert U, Holgate ST. Expression of CD44 isoforms is increased in the airway epithelium of asthmatic subjects. Am J Resp Cell Mol Biol 1997; 16:14-22.
33. Manolitsas ND, Trigg CJ, McAulay AE et al. The expression of adhesion molecule-1 and the beta-1 integrins in asthma. Eur Respir J 1994; 7:1439-44.
34. 3 (1 expression on fibronectin release by human pulmonary epithelial cells. Am J Respir Cell Mol Biol in press.
35. Laitinen A, Altraja A, Kämpe M, Linden M, Virtanen I, Laitinen L. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997; 156:951-8.
36. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; i:520-4.
37. Redington AE, Howarth PH. Airway wall remodelling in asthma. Thorax 1997; 52:310-2.
38. Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 1998; 53:21-7.
39. Brewster CEP, Howarth PH, Djukanovi R, Wilson J, Holgate ST, Roche WR. Myofibroblats and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3:507-11.
40. Gizycki MJ, Adelröth E, Rogers AV, O'Byrne PM, Jeffrey PK. Myofibroblast involvement in the allergen-indcued late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997; 16:664-73.
41. Zhang S, Howarth PH, Roche WR. Cytokine production by cell cultures from bronchial subepithelial myofibroblasts. J Pathol 1996; 180:95-101.
42. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156:229-33.
43. Hirst SJ. Airway smooth muscle cell culture: application to studies of airway wall remodelling and phenotype plasticity in asthma. Eur Respir J 1996; 9:808-20.
44. 1 in asthma. Measurement in bronchoalveolar fluid. Am J Respir Crit Care Med 1997; 156:642-7.
45. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G, Bousquet J. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156:591-9.
46. Redington AE, Madden J, Frew AJ, Djukanovi R, Roche WR, Holgate ST. Basic fibroblast growth factor in asthma: immunolocalisation in bronchial biopsies and measurement in bronchoalveolar lavage fluid at baseline following allergen challenge. Am J Respir Crit Care Med 1995; 151:A702.
47. Hoshino M, Nakamura Y, Sim JJ, Yamashiro Y, Uchida K, Kosaka K, Isogdi S. Inhaled corticosteroids reduced basement membrane thickness by modulation of insulin-like growth factor (IGF)-1 expression in bronchial asthma. Clin Exp Allergy 1997; in press.
48. Redington AE, Springall DR, Ghatei MAJ, Madden Bloom SR, Frew AJ, Polak J, Holgate ST, Howarth PH. Airway endothelin levels in asthma: Influence of endobronchial allergen challenge and maintenance corticosteroid therapy. Eur J Respir 1997; 10:1026-32.
49. Di Cosmo BF, Geba GP, Picarella D, Elias JA, Rankin JA, Stripp BR, Whitsett JA, Havell RA. Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest 1994; 94:2028-35.
50. Tang WL, Ray P, Wang P, Flavell RA, Elias JA. Targetted expression of interleukin 11 in murine airway causes lymphocyte infiltration, bronchial remodelling and airways obstruction. J Clin Invest 1996; 98:2845-53.
51. Knight DH, Lydell CP, Zhou D, Schellenberg RR, Bai TR. Distribution of leukaemia inhibitory factor (LIF) and its receptor in lung. Effect of IL-1β and IL-6 on gene expression and LIF release. J Immunol 1997; in press.
52. Zhang S, Smartt H, Holgate ST, Roche WR. Growth factors secereted by bronchial epithelial cells control myofibroblast proliferation: An in vitro co-culture model of airway remodelling in asthma. J Clin Invest submitted).
53. Campbell MJ, Cogman GR, Johnston SL, Holgate ST. Age specific trends in asthma mortality in England and Wales 1983-95: results of an observational study. Br Med J 1997; 314:1439-41.
54. Newton R, Kuitert LM, Slater DM, Adcock IM, Barnes PJ. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci 1997; 60:67-78.
55. Sousa A, Trigg CJ, Lane SJ, Hawksworth R, Nakhosteen JA, Poston RN, Lee TH. Effect of inhaled glucocorti coids on IL-1β and IL-1 receptor antagonist (IL-1ra) expression in asthmatic bronchial epithelium. Thorax 1997; 52:407-10.
56. Wilson S, Wallin A, Sandström T, Holgate ST. Effects of budesonide treatment on expression of NF-κB and NF-κB regulated cytokines and adhesion molecules in bronchial mucosa of mild asthmatics. Am J Respir Crit Care Med 1997; 155 (2):A698.
57. Stevenson EC, Turner G, Heaney LG et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy 1997; 27:1027-35.
58. Phunek P, Roche WR, Turzikova J, Kudrmann J, Warner JO. Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Respir J 1997; 19 (Suppl. 25):160s (abstract).
59. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156:737-43.
60. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344:219-24.
61. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153:1481-8.
62. Drazen JM, Israel E, O'Byrne P. Asthma treatment with agents modifying the 5-lipoxygenase pathway. N Engl J Med 1998; in press.